Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
| Details |  |
|---|---|
| Related links |  |
| Search |  |
Rchr
J-GLOBAL ID：202101013156984556
Update date: Jan. 09, 2025 Okamura Yasuyoshi
Okamura Yasuyoshi | Okamura Yasuyoshi
Clips
Kobe University
About Kobe University
Research theme for competitive and other funds (2)：
- 2020 - 2023 Development of novel bioabsorbable metal alloy for urinary tract surgery
- 2017 - 2020 Genome analysis during recurrence of urothelial cancer
- Takuto Hara, Hideto Ueki, Yasuyoshi Okamura, Yukari Bando, Kotaro Suzuki, Tomoaki Terakawa, Koji Chiba, Yoji Hyodo, Jun Teishima, Hideaki Miyake. Comparative prognostic value of tumor volume in IOIO and IOTKI treatment for metastatic renal cancer. Urologic Oncology: Seminars and Original Investigations. 2025. 43. 1. 63.e19-63.e27
- Takuto Hara, Jun Teishima, Yasuyoshi Okamura, Kotaro Suzuki, Yukari Bando, Tomoaki Terakawa, Koji Chiba, Yoji Hyodo, Yuzo Nakano, Hideaki Miyake. Appearance of New Lesions Associate With Poor Prognosis in Pembrolizumab-Treated Urothelial Carcinoma. Clinical Genitourinary Cancer. 2024. 22. 6. 102236-102236
- Takuto Hara, Kotaro Suzuki, Yasuyoshi Okamura, Hideto Ueki, Yukari Bando, Keisuke Okada, Tomoaki Terakawa, Yoji Hyodo, Koji Chiba, Jun Teishima, et al. Impact of neoadjuvant therapy on prognosis in renal cell carcinoma with inferior vena cava thrombus. Urologic Oncology: Seminars and Original Investigations. 2024
- Takuto Hara, Kotaro Suzuki, Yasuyoshi Okamura, Koji Chiba, Ryo Sato, Yuto Matsushita, Keita Tamura, Gaku Ishikawa, Atsushi Otsuka, Hideaki Miyake. Efficacy and safety of lenvatinib and pembrolizumab as first-line treatment for advanced renal cell carcinoma patients: real-world experience in Japan. International Journal of Clinical Oncology. 2024. 29. 12. 1931-1936
- Taisuke Tobe, Tomoaki Terakawa, Hideto Ueki, Takuto Hara, Yusuke Shiraishi, Naoto Wakita, Yasuyoshi Okamura, Kotaro Suzuki, Yukari Bando, Koji Chiba, et al. Initial Experience of Robot Assisted Laparoscopic Pyeloplasty for Ureteropelvic Junction Obstruction Using the Hinotori Surgical Robot System. The International Journal of Medical Robotics and Computer Assisted Surgery. 2024. 20. 5
- Tomoaki Terakawa, Kotaro Suzuki, Yasuyoshi Okamura, Yukari Bando, Takuto Hara, Junya Furukawa, Kenichi Harada, Nobuyuki Hinata, Yuzo Nakano, Masato Fujisawa. Clinical outcome of EP therapy (VP16+CDDP)in 10 prostate cancer patients with neuroendocrine differentiation. INTERNATIONAL JOURNAL OF UROLOGY. 2020. 27. 74-75
- Yukari Bando, Nobuyuki Hinata, Yusuke Shiraishi, Naoto Wakita, Mariko Sakamoto, Yasuyoshi Okamura, Kotaro Yuzuki, Takuto Hara, Tomoaki Terakawa, Junya Furukawa, et al. PREDICTIVE EFFICACYOF SERUMSOLUBLE PD-L1ONPATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH NIVOLUMAB. JOURNAL OF UROLOGY. 2020. 203. E239-E240
- 原琢人, 白石祐介, 脇田直人, 坂本茉莉子, 岡村泰義, 板東由加里, 鈴木光太郎, 寺川智章, 古川順也, 原田健一, et al. 当院における腎癌患者のニボルマブとイピリムマブ併用療法の治療成績. 西日本泌尿器科. 2020. 82
- Yukari Bando, Mariko Sakamoto, Yasuyoshi Okamura, Kotaro Suzuki, Takuto Hara, Tomoaki Terakawa, Junya Furukawa, Kenichi Harada, Nobuyuki Hinata, Yuzo Nakano, et al. NEUTROPHIL-TO-LYMPHOCYTE RATIO AS A PREDICTIVE BIOMARKER FOR RESPONSE TO NIVOLUMAB IN ASIAN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA. JOURNAL OF UROLOGY. 2019. 201. 4. E344-E345
- 古川 順也, 坂本 茉莉子, 岡村 泰義, 板東 由加里, 鈴木 光太郎, 原 琢人, 寺川 智章, 原田 健一, 日向 信之, 中野 雄造, et al. 淡明細胞型腎細胞癌に対するfirst-line Sunitinibの治療成績. 日本泌尿器科学会総会. 2019. 107回. OP-141
-
当院における精巣腫瘍の臨床的検討
(2020)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.
Return to Previous Page
